Ischemic heart disease (IHD) is a global burden, and it remains the leading cause of death worldwide. Accurate assessment of the presence and extent of IHD is a crucial step in the management of this condition. Noninvasive imaging plays a vital role in the diagnosis and risk stratification of patients. Over the last decade, cardiac magnetic resonance (CMR) imaging has emerged as a very promising noninvasive imaging modality in the assessment of IHD due to its multiparametric nature, high spatial resolution, high reproducibility, and superior tissue characterization properties, all of which are reflected in a large body of evidence in the literature. CMR provides comprehensive information in the assessment of IHD, which guides the detection and differential diagnosis, assists in the clinical decision-making process, and improves risk stratification.
|Number of pages||10|
|Journal||Dialogues in Cardiovascular Medicine|
|Publication status||Published - 2016|
Bibliographical noteFunding Information:
This work was supported by the Bristol NIHR Cardiovascular Biomedical Research Unit at the Bristol Heart Institute. The views expressed are those of the authors and not necessarily those of the UK National Health Service, National Institute for Health Research, or Department of Health.
© 2016, AICH - Servier Research Group. All rights reserved.
Copyright 2017 Elsevier B.V., All rights reserved.
- Cardiovascular magnetic resonance
- Ischemic heart disease